Evidence map›Paper›PMID 28458415›Full record

SynthesisIndian journal of pharmacology

Is aura around citicoline fading? A systemic review.

Saurabh Agarwal, Bhoomika M Patel

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Indian journal of pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Current neuroprotective agents in stroke.Turkish journal of physical medicine and rehabilitation · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saurabh AgarwalDepartment of Pharmacology, Nirma University, Ahmedabad, Gujarat, India.
Bhoomika M PatelDepartment of Pharmacology, Nirma University, Ahmedabad, Gujarat, India.
Nirma University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke and traumatic brain injury (TBI) are the critical public health and socioeconomic problems throughout the world. At present, citicoline is used as a coadjuvant for the management of acute ischemic stroke (AIS) and TBI in various countries. This systemic review analyzes the beneficial role of citicoline in AIS and TBI. This systemic review is based on "PubMed" and "Science Direct" search results for citicoline role in stroke and TBI. In this systemic review, we included 12 human trials. A meta-analysis was performed on the basis of neurological evaluation, functional evaluation and Glasgow outcome scale, domestic adaptation evaluation outcomes, and cognitive outcome individually. In neurological evaluation, domestic adaptation evaluation, and cognitive outcomes, there was no significant difference in both the citicoline and placebo groups (odds ratio [OR] = 1.04 [0.9-1.2,

Indexed as

Brain Injuries, TraumaticBrain IschemiaCytidine Diphosphate CholineStrokeCognitionHumansNootropic AgentsTreatment OutcomeCytidine Diphosphate CholineNootropic AgentsAcute ischemic stroke recoveryBarthel Index scoreciticolineGlasgow outcome scalemodified Rankin scaleNational Institutes of Health Stroke Scaletraumatic brain injury

Identifiers

PMID28458415
PMCPMC5351236
OpenAlexW2604695648

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.